| breast cancer - triple negative | |||||
| mBC - Triple negative (TNBC) - 1st Line (L1) | la/mBC - TNBC - L2 - all population | la/mBC - TNBC - L2 - PDL1 positive | es-BC - Triple negatif (TNBC) - (neo)adjuvant (NA) | es-BC - TNBC - NA - all population | |
| non platinum-based chemotherapy | |||||
| nucleoside analogues (pyrimidine/purine) | |||||
| gemcitabine | IMpassion-132 ... IMpassion-132 ... | IMpassion-132 ... IMpassion-132 ... | |||
| taxanes | |||||
| docetaxel | BCTOP-T-A01 arm A/B | ||||
| paclitaxel | |||||
| nab-paclitaxel | FUTURE-SUPER_immunomodulatory subtype | GeparNuevo | |||
Study type:
delta: difference in rate or median (if available)
-
About us
-
Contact us
-
Method
-
RSS
Made with
in Lyon
-
Credits
-
Privacy policy
-
